Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Beuvery

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1994
Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infantsS Simasathien, S Migasena, C Beuvery, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1997
A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccineD J Wood, A B Heath, G F Kersten, et al.
Vaccine|March 1, 1987
O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharideP A van de Wiel, M H Witvliet, D Evenberg, et al.
Infection and Immunity|February 1, 1989
Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopyM Pâques, J S Teppema, E C Beuvery, et al.
Journal of Immunological Methods|December 15, 1991
An isotype-specific spot-ELISA for the enumeration of antibody-secreting hybridomas and the determination of isotype switch variantsJ M Coco-Martin, P Koolwijk, C A van der Velden-de Groot, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 5, 1997
Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic siteL A Sawyer, D Wood, M Ferguson, et al.
The Journal of Infection|May 1, 1983
Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugateE C Beuvery, F Miedema, R W van Delft, et al.
Cytotechnology|January 1, 1993
Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture ageJ M Coco-Martin, D E Martens, T A van der Velden-de Groot, et al.
Cytotechnology|February 24, 2012
Batch control system vaccines: BCSV : A new man machine interface for bioreactorsG Wieten, R C Dorresteijn, M C Philippi, et al.
Cytotechnology|January 1, 1992
Viability measurements of hybridoma cells in suspension culturesJ M Coco-Martin, J W Oberink, T A van der Velden-de Groot, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Scandinavian Journal of Infectious Diseases|January 1, 1994
Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infantsS Simasathien, S Migasena, C Beuvery, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1997
A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccineD J Wood, A B Heath, G F Kersten, et al.
Vaccine|March 1, 1987
O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharideP A van de Wiel, M H Witvliet, D Evenberg, et al.
Infection and Immunity|February 1, 1989
Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopyM Pâques, J S Teppema, E C Beuvery, et al.
Journal of Immunological Methods|December 15, 1991
An isotype-specific spot-ELISA for the enumeration of antibody-secreting hybridomas and the determination of isotype switch variantsJ M Coco-Martin, P Koolwijk, C A van der Velden-de Groot, et al.
Biologicals : Journal of the International Association of Biological Standardization|November 5, 1997
Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic siteL A Sawyer, D Wood, M Ferguson, et al.
The Journal of Infection|May 1, 1983
Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugateE C Beuvery, F Miedema, R W van Delft, et al.
Cytotechnology|January 1, 1993
Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture ageJ M Coco-Martin, D E Martens, T A van der Velden-de Groot, et al.
Cytotechnology|February 24, 2012
Batch control system vaccines: BCSV : A new man machine interface for bioreactorsG Wieten, R C Dorresteijn, M C Philippi, et al.
Cytotechnology|January 1, 1992
Viability measurements of hybridoma cells in suspension culturesJ M Coco-Martin, J W Oberink, T A van der Velden-de Groot, et al.
Pageof 8